Literature DB >> 2508129

Cyclooxygenase and lipoxygenase pathways in anterior uvea and conjunctiva.

P S Kulkarni1, B D Srinivasan.   

Abstract

It has been demonstrated that normal, uninflamed, anterior uvea and conjunctiva of different species have the capacity to synthesize cyclooxygenase and lipoxygenase products. Cyclooxygenase activity is greater than lipoxygenase activity in both anterior uvea and conjunctival tissues. Other ocular tissues such as cornea, lens, and retina were found to have much lesser capacity than the conjunctiva and anterior uvea to synthesize cyclooxygenase and lipoxygenase products from arachidonic acid. In our preliminary studies, we also observed that human retina have considerably less ability to metabolize AA into cyclooxygenase and lipoxygenase activity. The finding that the anterior uvea of all species studied has a high capacity to synthesize PGs and other cyclooxygenase products maybe of particular physiological significance since several investigators have demonstrated that PGE2 and PGF2 alpha in low doses, lower intraocular pressure in all species studied, including the human eye. Additionally, PGE2 can be shown to have some anti-inflammatory effects. In light of these observations, we must consider that the high endogenous cyclooxygenase activity in normal conjunctiva and anterior uvea may play a role in maintaining normal intraocular pressure and in preventing the development of inflammation in response to normal environmental stimuli. Arachidonic acid is also metabolized into biologically active compounds by cytochrome P450 in corneal endothelium. It is not yet known whether or not other ocular tissues also have the ability to metabolize arachidonic acid via this pathway and whether these compounds, when synthesized from endogenous arachidonic acid stores in vivo have any biological effects on the eye. Studies on omega-3 fatty acid metabolism were done for two main reasons: (1) PGE3 and PGD3 lowered intraocular pressure without causing ocular inflammation in rabbit; and (2) some surveys demonstrated that in Greenland Eskimos whose marine diet is enriched with omega-3 substrate eicosapentaenoic acid, have a lower incidence of open-angle glaucoma as compared to Caucasians, whose diet is rich in arachidonic acid. The ability of anterior uvea to synthesize PGE3 and PGD3 in human, monkey, and rabbit anterior uvea warrants further investigation to determine whether or not these omega-3 PGs play a role in lowering intraocular pressure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508129

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  8 in total

Review 1.  The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology.

Authors:  P Koay
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

Review 2.  Immunoresolvent Resolvin D1 Maintains the Health of the Ocular Surface.

Authors:  Darlene A Dartt; Robin R Hodges; Charles N Serhan
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

3.  Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation.

Authors:  L David Waterbury; Danielle Galindo; Linda Villanueva; Cathy Nguyen; Milan Patel; Lisa Borbridge; Mayssa Attar; Rhett M Schiffman; David A Hollander
Journal:  J Ocul Pharmacol Ther       Date:  2011-02-25       Impact factor: 2.671

4.  Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice.

Authors:  Shailaja Hegde; Naveen Kaushal; Kodihalli C Ravindra; Christopher Chiaro; Kelsey T Hafer; Ujjawal H Gandhi; Jerry T Thompson; John P van den Heuvel; Mary J Kennett; Pamela Hankey; Robert F Paulson; K Sandeep Prabhu
Journal:  Blood       Date:  2011-10-03       Impact factor: 22.113

5.  Polyunsaturated fatty acids induce modification in the lipid composition and the prostaglandin production of the conjunctival epithelium cells.

Authors:  Sabrina Viau; Laurent Leclère; Bénédicte Buteau; Stéphane Grégoire; Niyazi Acar; Alain Bron; Catherine P Creuzot-Garcher; Lionel Bretillon; Corinne Joffre
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-06       Impact factor: 3.117

6.  Intraocular adrenaline maintains mydriasis during cataract surgery.

Authors:  M C Corbett; A B Richards
Journal:  Br J Ophthalmol       Date:  1994-02       Impact factor: 4.638

7.  Alkalinization in peribulbar anesthesia for surgery on inflamed eye.

Authors:  Swati Zawar
Journal:  Indian J Ophthalmol       Date:  2011 May-Jun       Impact factor: 1.848

Review 8.  Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy.

Authors:  Tirth J Shah; Mandi D Conway; Gholam A Peyman
Journal:  Clin Ophthalmol       Date:  2018-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.